This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, J. J. Articles by Antonia Li, S. Search for Related Content PubMed PubMed Citation Articles by Li, J. J. Articles by Antonia Li, S.

Overexpression and Amplification of c-myc in the Syrian Hamster Kidney during Estrogen Carcinogenesis

A Probable Critical Role in Neoplastic Transformation¹

Hormonal Carcinogenesis Laboratory, Division of Etiology and Prevention of Hormonal Cancers, University of Kansas Cancer Institute, and Departments of Pharmacology, Toxicology and Therapeutics [J. J. L., S. A. L.], and Preventive Medicine [J. J. L.], University of Kansas Medical Center, Kansas City, Kansas 66160-7312, and Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, South Carolina 29425 [F. M., J. S. N.]

An estrogen receptor-driven, multistep process for estrogen carcinogenesis in the Syrian hamster kidney is proposed. Because in this species the reproductive and urogenital tracts arise from the same embryonic germinal ridge, it is evident that the kidney has carried over genes that are responsive to estrogens. Using in situ hybridization, overexpression of early estrogen-response genes, i.e., c-myc and c-fos, has been shown to be localized preferentially in early renal tumor foci after 3.5–4.0 months of estrogen treatment. This event coincides with an increased number of S-phase proliferating cell nuclear antigen-labeled cells in these tumor foci, along with a rapid rise in aneuploid frequency in the kidney. Western blot analyses of c-MYC and c-FOS protein products support the overexpression of these genes. Amplification of c-myc, 2.4–3.6-fold, but not of c-fos, was detected in 67% of the primary renal tumors examined, by Southern blot analyses. Consistent chromosomal gains, common to both diethylstilbestrol- and estradiol-induced renal neoplasms, were observed in chromosomes 1, 2, 3, (6) , 11, (13) , 16, 20, and 21 (chromosome number alterations are indicated in parentheses). Using fluorescence in situ hybridization, the c-myc gene was localized to hamster chromosome 6qb. Chromosome 6 exhibited a high frequency of trisomies and tetrasomies in the kidney after 5.0 months of estrogen treatment and in primary renal tumors. The data presented indicate that estrogen-induced genomic instability may be a key element in carcinogenic processes induced by estrogens.

This article has been cited by other articles:

				A. E. Hontz, S. A. Li, W. L. Lingle, V. Negron, A. Bruzek, J. L. Salisbury, and J. J. Li Aurora A and B Overexpression and Centrosome Amplification in Early Estrogen-Induced Tumor Foci in the Syrian Hamster Kidney: Implications for Chromosomal Instability, Aneuploidy, and Neoplasia Cancer Res., April 1, 2007; 67(7): 2957 - 2963. [Abstract] [Full Text] [PDF]

				T. Miyamoto, T. Shiozawa, H. Kashima, Y.-Z. Feng, A. Suzuki, M. Kurai, T. Nikaido, and I. Konishi Estrogen Up-Regulates Mismatch Repair Activity in Normal and Malignant Endometrial Glandular Cells Endocrinology, October 1, 2006; 147(10): 4863 - 4870. [Abstract] [Full Text] [PDF]

				J. J. Li, S. J. Weroha, W. L. Lingle, D. Papa, J. L. Salisbury, and S. A. Li Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats PNAS, December 28, 2004; 101(52): 18123 - 18128. [Abstract] [Full Text] [PDF]

				A. S. Parker, J. R. Cerhan, C. F. Lynch, A. G. Ershow, and K. P. Cantor Gender, Alcohol Consumption, and Renal Cell Carcinoma Am. J. Epidemiol., March 1, 2002; 155(5): 455 - 462. [Abstract] [Full Text] [PDF]

				J. J. Li, S. J. Weroha, M. F. Davis, O. Tawfik, X. Hou, and S. A. Li ER and PR in Renomedullary Interstitial Cells During Syrian Hamster Estrogen-Induced Tumorigenesis: Evidence for Receptor-Mediated Oncogenesis Endocrinology, September 1, 2001; 142(9): 4006 - 4014. [Abstract] [Full Text] [PDF]

				C. E. Hudson, B. A. Schulte, T. R. Sutter, and J. S. Norris Steroid hormones modulate expression of cytochrome P450 enzymes in male hamster reproductive tract and leiomyosarcomas Carcinogenesis, May 1, 2001; 22(5): 763 - 770. [Abstract] [Full Text] [PDF]

				R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]

				D.-Z. J. Liao, X. Hou, S. Bai, S. Antonia Li, and J. J. Li Unusual deregulation of cell cycle components in early and frank estrogen-induced renal neoplasias in the Syrian hamster Carcinogenesis, December 1, 2000; 21(12): 2167 - 2173. [Abstract] [Full Text] [PDF]

				J. G. Liehr Is Estradiol a Genotoxic Mutagenic Carcinogen? Endocr. Rev., February 1, 2000; 21(1): 40 - 54. [Abstract] [Full Text]

				K. Datta, R. Nambudripad, S. Pal, M. Zhou, H. T. Cohen, and D. Mukhopadhyay Inhibition of Insulin-like Growth Factor-I-mediated Cell Signaling by the von Hippel-Lindau Gene Product in Renal Cancer J. Biol. Chem., June 30, 2000; 275(27): 20700 - 20706. [Abstract] [Full Text] [PDF]